AI眼鏡概念拉昇:創維數字10CM直線升停,顯盈科技20CM直線升停
A股市場AI眼鏡概念股拉昇,其中,顯盈科技20CM直線升停,創維數字10CM直線升停,寶鷹股份、中科藍訊、緯達光電、億道信息、博士眼鏡等跟升。消息面上,近期,Meta宣佈與眼鏡集團EssilorLuxottica合作,計劃在其售價300美元的太陽鏡中加入顯示屏。據悉,新版眼鏡可能最早將在2025年下半年推出,顯示屏可能用於展示通知或來自Meta虛擬助手的回覆。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.